益生菌与益生元在烧伤患者中的干预:系统综述
该系统综述检索2000年至2025年PubMed、Scopus和Medline数据库,纳入9项研究共426例烧伤患者,评估益生菌与益生元对脓毒症、死亡率、感染和血清IgA等结局的影响。益生菌组感染率显著降低(p<0.0001)、血清IgA显著升高(p<0.0001),但脓毒症率(p=0.42)和死亡率(p=0.32)无统计学显著差异。
要点
- 益生菌组感染率较对照组显著降低(p<0.0001)。
- 益生菌组血清IgA较对照组显著升高(p<0.0001)。
- 脓毒症率与死亡率组间无统计学显著差异。
核心结论
- 益生菌与益生元整合入烧伤护理是值得未来研究的有前景方向,其安全性良好且新兴证据提示可能增强免疫功能、减少感染相关并发症并改善患者结局。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索PubMed、Scopus和Medline从2000年1月1日至2025年1月1日,检索词为(「Probiotics」OR「Prebiotics」)AND「Burns」。
- 纳入9项研究共426例患者,由两名评价者独立筛选标题、摘要和全文,并按牛津循证医学中心指南分配证据等级。
- 该系统综述已在PROSPERO注册(CRD420251010368)。
主要发现
- 益生菌治疗组与对照组脓毒症率无统计学显著差异(p=0.42)。
- 益生菌治疗组与对照组死亡率无统计学显著差异(p=0.32)。
- 益生菌治疗组感染率较对照组有统计学显著下降(p<0.0001)。
- 益生菌治疗组血清IgA较对照组有统计学显著升高(p<0.0001)。
- 一项研究报告益生菌联合益生元治疗组较对照组第24天创面面积显著缩小(p=0.001)。
临床怎么用
- 基于现有证据,益生菌与益生元可作为烧伤患者安全性良好的辅助治疗选择,可能有助于降低感染率并提升血清IgA水平。
- 对脓毒症率和死亡率的影响尚不明确,临床决策需结合个体情况并关注新兴证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burn injuries represent a significant global health burden, accounting for approximately 180,000 deaths annually. Probiotic and prebiotic use may offer a safe adjunctive therapy to reduce complications and enhance recovery in burn patients. This systematic review aims to evaluate current literature on the effects of probiotics and prebiotics for key outcomes in burn patients, such as sepsis, mortality, infection, and serum IgA levels. METHODS: A systematic review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines by searching PubMed, Scopus, and Medline between January 1, 2000, and January 1, 2025, with the search terms (("Probiotics" OR "Prebiotics") AND "Burns"). This review was registered on the International Prospective Register of Systematic Reviews (PROSPERO) website (CRD420251010368). Titles, abstracts, and full texts were independently screened by two reviewers. Included studies were assigned a level of evidence per Oxford Centre for Evidence-based Medicine guidelines. RESULTS: Data from 9 studies with a total of 426 patients were identified. There were no statistically significant differences between probiotic treatment and control groups for sepsis rate (p = 0.42) or mortality (p = 0.32), but there was a statistically significance decrease in the probiotic treatment group's rate of infection (p < 0.0001) and a statistically significant increase in serum IgA (p < 0.0001). One study reported significant reduction in wound area for the combined probiotic and prebiotic treatment group compared to control at day 24 (p = 0.001), while another reported shorter duration to reach 95 % wound area reduction in the probiotic treatment group compared to control, though not statistically significant (p = 0.230). CONCLUSIONS: This systematic review analysed the impact of probiotics and prebiotics on key outcomes in burn injury patients to assess their potential as a cost-effective and low-risk therapeutic intervention. Integration of probiotics and prebiotics into burn care represents a promising avenue for future investigation, given their favorable safety profile and emerging evidence suggesting potential benefits in enhancing immune function, reducing infection-related complications, and improving patient outcomes.
引用
- Thiagarajan AB, Narloch K, Chernyak M, et al. Probiotic and prebiotic interventions in burn patients: A systematic review. Burns. 2026. PMID: 41707541. doi:10.1016/j.burns.2026.107912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。